Saturday - April 19, 2025
FDA Clears IND for Clinical Trial Testing Switchable CAR-T Therapy in Patients With Autoimmune Diseases, Without Chemotherapy
April 10, 2025
LA JOLLA, California, April 10 -- The Scripps Research Institute issued the following news on April 9, 2025:

* * *

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy

Innovative cellular therapy has potential to treat patients with lupus, systemic sclerosis, myositis and RA without chemotherapy-induced immune suppression.

LA JOLLA, CA--Calibr-Skaggs Institute for Innovati . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products